Function Therapeutics, a firm performing medicinal chemistry and pharmacology at UWM since June 2022, recently received a Phase 1 SBIR award from the National Science Foundation. The grant, Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1), will support… Read More
We are happy to share that Avik Roy working as CSO at Simmaron Research received a NIH R21 grant in the amount of $450,000. The purpose of the grant is to study the role of autophagy-related protein ATG13 in the… Read More
We are delighted to announce that three excellent faculty from the Department of Biomedical Science have joined the Milwaukee Institute for Drug Discovery. Professor Janis Eells (left) is a pharmacologist with an appointment as Adjunct Professor at the Medical College… Read More